Alimera Sciences (NASDAQ:ALIM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Separately, Maxim Group initiated coverage on Alimera Sciences in a research note on Monday, March 25th. They set a “buy” rating and a $10.00 price objective on the […]
Alimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alimera Sciences (NASDAQ:ALIM) Shares Pass Above 200-Day Moving Average of $2 35 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. Craig Hallum decreased their target price on shares of Alimera Sciences from […]
Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report issued on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the stock. HC Wainwright restated a “buy” rating and issued a […]